1. Introduction {#sec1}
===============

The prevalence of metabolic syndrome in Malaysia is higher than in other Asian countries,[@bib1] mainly due to the high prevalence of obesity.[@bib2] However, there are many individuals who are not categorized as obese based on body mass index (BMI) but are predisposed to metabolic disorders.[@bib3] Screening for metabolic disorders among these non-obese individuals is often ignored, as they are assumed to be healthy. The literature shows that normal weight individuals could have metabolic disorders, placing them at elevated risk for chronic diseases that are typically associated with elevated BMI.[@bib4] Evidence also suggests that an abnormal metabolic profile, rather than high BMI, is associated with higher risk of diabetes and cardiovascular disease.[@bib5]

Individuals who are normal-to over-weight with metabolic syndrome have been broadly classified as metabolically obese, non-obese (MONO).[@bib6], [@bib7], [@bib8] However, the classification of MONO was complicated by the limitations associated with utilizing BMI in the definition. MONO was previously defined as individuals with BMI \<27.0 kg/m^2^ [@bib6], [@bib7] or \<25.0 kg/m^2^ [@bib8] who have metabolic syndrome. However, based on World Health Organization (WHO) classification, the definition of non-obese is BMI 18.5--29.9 kg/m^2^.[@bib9] Malaysia has the highest prevalence of overweight population in the Southeast Asia,[@bib10] so knowing the metabolic risk among this group is crucial for public health action and clinical practice.

MONO offers insight into the risks of metabolic syndrome independent of obesity. Several studies have reported that non-obese individuals with metabolic risk factors display characteristic such as insulin resistance and higher visceral adiposity and plasma triglyceride, which together may confer an increased risk of cardiometabolic disease.[@bib11] Moreover, identifying MONO may be more important among Asians, who are generally less obese but have relatively higher body fat than Westerners with the same BMI.[@bib9], [@bib12]

Therefore, the aim of this study was to describe the prevalence and distribution of MONO using a BMI criterion of 18.5--29.9 kg/m^2^ among the adult population in the state of Melaka, Malaysia.

2. Methods {#sec2}
==========

This was a cross-sectional study carried out using multi-stage sampling in a school setting. A total of 51 public secondary schools were randomly selected. All permanent school teachers from the selected schools were invited to participate. Teachers who had psychiatric illnesses, were pregnant, or had a BMI \<18.5 or ≥30.0 kg/m^2^ were excluded. Data collection was carried out from October 2013 until February 2014. Information on socio-demographic characteristics and lifestyle behaviours were enquired using self-administered questionnaires. Anthropometric measurements and metabolic risk assessments were conducted by trained research assistants as per protocol.[@bib13] This study is part of a cohort study on clustering of lifestyle risk factors and understanding its association with stress on health and wellbeing among school teachers in Malaysia (CLUSTer).[@bib13]

This study was approved by the University Malaya Medical Ethics Committee (Ref No. 950.1) and written permission was granted from the Ministry of Education, the Education Department, and the school principals. Informed consent was obtained from all participants.

2.1. Definition of metabolic syndrome {#sec2.1}
-------------------------------------

Metabolic syndrome was defined using the Harmonization criteria as having any three or more of the following risk factors: (1) central obesity (waist circumference \[WC\] ≥80 cm in women or ≥90 cm in men); (2) elevated triglyceride (TG; ≥1.7 mmol/L); (3) low high-density lipoprotein cholesterol (HDL-C; ≤1.3 mmol/L in women or ≤1.0 mmol/L in men); (4) high blood pressure (BP; ≥130/85 mm Hg or on antihypertensive treatment); and (5) high fasting blood glucose (FBG; ≥5.6 mmol/L or on treatment for elevated glucose).[@bib14]

2.2. Definition of MONO {#sec2.2}
-----------------------

MONO was defined as individuals with BMI 18.5--29.9 kg/m^2^ with metabolic syndrome. These individuals were subdivided into four BMI categories (18.5--22.99, 23.00--24.99, 25.00--27.49, and 27.50--29.99 kg/m^2^) according to the BMI cut-off points as defined by WHO.[@bib9]

2.3. Statistical analyses {#sec2.3}
-------------------------

Data entry and analysis were undertaken using the IBM SPSS Statistic version 21.0 (IBM Corp, Armonk, NY, USA). Samples were weighted to account for unequal probabilities of selection and non-response rate. Complex sample multivariate logistic regression analysis was conducted to estimate the odds ratio (OR) with 95% confidence interval (CI) of metabolic syndrome among non-obese individuals (MONO) adjusted for modifiable and non-modifiable confounders.

3. Results {#sec3}
==========

A total of 1511 teachers were recruited, yielding a response rate of 36.0%. After excluding the underweight and obese, 1168 participants (78.4%) were included in the analysis. The majority of participants were females, Malays, and had tertiary education, with a mean age of 42.5 years ([Table 1](#tbl1){ref-type="table"}). The prevalence of MONO was 17.7% (95% CI, 15.3--20.4), whereas the prevalence of metabolic syndrome among the normal weight and overweight participants was 8.3% (95% CI, 5.8--11.8) and 29.9% (95% CI, 26.3--33.7), respectively ([Table 2](#tbl2){ref-type="table"}). The prevalence of MONO was higher among males (*P* = 0.004) and Indians (*P* = 0.006) and increased with age (*P* \< 0.001). Participants with metabolic syndrome were significantly older (by approximately five years) and had shorter sleep duration (by approximately half an hour). There was no significant difference in the prevalence of metabolic syndrome according to the levels of education, physical activity, smoking status, alcohol consumption, or fruits and vegetables intake ([Table 1](#tbl1){ref-type="table"}).

Regardless of BMI status (normal and/or overweight), participants with central obesity were more likely to have metabolic syndrome compared to those without central obesity (*P* \< 0.001), whereas, among participants without central obesity, only 4--8% were diagnosed with metabolic syndrome ([Table 2](#tbl2){ref-type="table"}).

The number of metabolic risk factors according to BMI categories is shown in [Fig. 1](#fig1){ref-type="fig"}. The proportion of participants with no metabolic risk factors reduced with BMI (*P*~trend~ \< 0.001), while the proportion of participants with two to four metabolic risk factors increased significantly with BMI. There were no participants with five metabolic risk factors in the normal BMI categories. The proportion of participants with metabolic syndrome increased with BMI (*P*~trend~ \< 0.001).

The associations between BMI categories and metabolic syndrome are presented in [Table 3](#tbl3){ref-type="table"}. Higher BMI categories conferred higher crude and adjusted OR for metabolic syndrome. The unadjusted odds of metabolic syndrome increased exponentially from 2.5 (at BMI 23.0--24.9 kg/m^2^) to 10.3 (at BMI 27.5--29.9 kg/m^2^) compared to those with BMI 18.5--22.9 kg/m^2^. The adjusted odds of metabolic syndrome in models 1 and 2 were comparable those in the unadjusted model.

4. Discussion {#sec4}
=============

The prevalence of MONO among our participants was about 18%, with male predominance. Previous studies have shown that the prevalence of metabolic syndrome among Taiwanese with BMI \<27.0 kg/m^2^ was 18.7%[@bib6] and that the prevalence among South Indians with BMI \<25.0 kg/m^2^ was 15.1%.[@bib8]

MONO was most prevalent among our participants of Indian ethnicity, as they had higher tendency to develop central obesity, hypertension, dyslipidaemia, hyperinsulinemia, and glucose intolerance, as has been reported elsewhere.[@bib15], [@bib16] Older age participants also had higher prevalence of MONO, so it is important to screen the older population for metabolic risk factors even if they are non-obese. Lifestyle risk factors, such as physical activity, smoking, alcohol, fruit and vegetable consumption, and sleep duration were reported to contribute to metabolic syndrome.[@bib17], [@bib18] However, in our study, only sleep duration was found to be significantly associated with MONO; an inverse relationship between sleep and metabolic syndrome has also been reported in a recent meta-analysis.[@bib19]

Central obesity is not compulsory in diagnosing metabolic syndrome using the Harmonization criteria. However, our results showed that those with central obesity had higher risk of metabolic syndrome regardless of being normal weight or overweight. One possible explanation might be because central obesity was the most frequently reported metabolic risk factor among our participants (data not shown), and central obesity could be a proxy for insulin resistance, which would increase the risk of developing metabolic syndrome.[@bib20], [@bib21]

Our study showed that the prevalence of metabolic syndrome and the number of metabolic risk factors increased with BMI, findings that have been similarly reported by others.[@bib6], [@bib22], [@bib23], [@bib24] These findings support the notion that weight gain is detrimental to metabolic health. We found that the adjusted odds of metabolic syndrome increased exponentially from a BMI of 23.0 kg/m^2^, in agreement with the recommendations,[@bib9] where BMI 23.0 kg/m^2^ was identified as an additional trigger point for public health action among Asians.

There were several limitations in our study that need to be addressed. First, the prevalence of MONO is difficult to quantify, as there is presently no standardized definition for MONO, resulting in a wide variation in its prevalence. Our results may not be generalizable to the general population, as the majority of our participants were females, Malays, and had tertiary education, representing the characteristics of the secondary school teachers in our country. In addition, the cross-sectional design does not allow us to establish causal relationships. Finally, recall bias could not be ruled out, as lifestyle behaviours were self-reported.

However, to the best of our knowledge, this is the first study to investigate the prevalence of MONO in Malaysia. In addition, the BMI categories were based on WHO cut-off points,[@bib9] unlike other studies where cut-off points were chosen arbitrarily.[@bib6], [@bib7], [@bib8] It is now clear that MONO is prevalent among our participants and they are susceptible to developing diabetes and cardiovascular disease, which may lead to cardiovascular or all-cause mortality.[@bib5], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29] Detection of MONO individuals might be particularly noteworthy, since they might be more responsive to dietary and lifestyle interventions, which may reduce their subsequent risk of cardiovascular complications.[@bib3], [@bib30] Furthermore, it is practical, cost-effective, and feasible to identify MONO individuals in a large population using our already established health care system.

In conclusion, the prevalence of MONO was high and increased with BMI among our participants. Participants with BMI ≥23.0 kg/m^2^ had significantly higher odds of metabolic syndrome after adjustment. MONO was more prevalent among males, Indians, and those of older age, and was inversely associated with sleep duration. Healthcare professionals should start screening normal weight and overweight individuals for metabolic risk factors. Health promotion programs should be targeted on MONO individuals to increase their awareness of cardiometabolic risks and gear them towards taking preventive measures. Future studies should be conducted among populations from more diverse occupations, with a more nationally representative ethnic and gender distribution. Longitudinal studies should also be carried out to establish causal relationship between metabolic syndrome and its risk factors.
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###### 

Socio-demographic characteristics and lifestyle risk factors of participants.

Table 1

                                          Total n        MONO           *P* value      
  --------------------------------------- -------------- -------------- -------------- -----------
  Age group, years                                                                     
   20--29                                 113            6 (5.6)        107 (94.4)     \<0.001
   30--39                                 319            32 (10.5)      287 (89.5)     
   40--49                                 430            87 (17.5)      343 (82.5)     
   50--59                                 306            92 (29.4)      214 (70.6)     
  Gender                                                                               
   Male                                   280            72 (25.9)      208 (74.1)     0.004
   Female                                 888            146 (15.2)     742 (84.8)     
  Ethnicity                                                                            
   Malay                                  897            165 (17.7)     732 (82.3)     0.005
   Chinese                                216            34 (14.9)      182 (85.1)     
   Indian                                 40             16 (39.3)      24 (60.7)      
   Others                                 15             2 (7.8)        13 (92.2)      
  Level of education                                                                   
   Diploma                                37             5 (19.1)       32 (80.9)      0.451
   Degree                                 1035           1868 (17.2)    847 (82.8)     
   Master/PhD                             96             25 (23.3)      71 (76.7)      
  Level of physical activity                                                           
   Low                                    103            21 (15.2)      82 (84.8)      0.617
   Moderate                               453            84 (18.6)      369 (81.4)     
   High                                   275            59 (20.0)      216 (80.0)     
  Smoking status                                                                       
   Current                                28             7 (21.5)       21 (78.5)      0.870
   Former                                 43             9 (19.2)       34 (80.8)      
   Never                                  955            177 (17.6)     778 (82.4)     
  Alcohol consumption                                                                  
   Yes                                    34             10 (25.7)      24 (74.3)      0.219
   No                                     1020           186 (17.2)     834 (82.8)     
                                          Mean (SE)      Mean (SE)      Mean (SE)      *P* value
  Age, years                              42.51 (0.49)   46.72 (0.72)   41.60 (0.50)   \<0.001
  Servings of fruits and vegetables/day   2.35 (0.04)    2.39 (0.10)    2.34 (0.05)    0.644
  Sleep, hours per day                    6.26 (0.05)    5.97 (0.08)    6.32 (0.06)    0.001

MONO, metabolically obese, non-obese; SE, standard error.

###### 

The proportion of metabolic syndrome according to fatness categories.

Table 2

  **Fatness categories**                               Metabolic syndrome   *P* value    
  ---------------------------------------------------- -------------------- ------------ ---------
  Normal weight[b](#tbl2fnb){ref-type="table-fn"}      55 (8.3)             577 (91.7)   
   Central obesity[a](#tbl2fna){ref-type="table-fn"}   35 (24.6)            92 (75.4)    \<0.001
   Non-central obesity                                 20 (4.2)             485 (95.8)   
  Overweight[c](#tbl2fnc){ref-type="table-fn"}         163 (29.9)           373 (70.1)   
   Central obesity[b](#tbl2fnb){ref-type="table-fn"}   149 (40.7)           212 (59.3)   \<0.001
   Non-central obesity                                 14 (8.4)             161 (91.6)   
  Total (MONO)[d](#tbl2fnd){ref-type="table-fn"}       218 (17.7)           950 (82.3)   
   Central obesity[a](#tbl2fna){ref-type="table-fn"}   184 (36.2)           304 (63.8)   \<0.001
   Non-central obesity                                 34 (5.3)             646 (94.7)   

MONO, metabolically obese, non-obese.

Male ≥90 cm; female ≥80 cm.

BMI 18.5--24.9 kg/m^2^.

BMI 25.0--29.9 kg/m^2^.

BMI 18.5--29.9 kg/m^2^.

###### 

The odds ratios of metabolic syndrome according to BMI categories.

Table 3

  BMI categories, kg/m^2^   n     Unadjusted            Model 1   Model 2                                              
  ------------------------- ----- --------------------- --------- -------------------- --------- --------------------- ---------
  18.5 to 22.9              376   1                               1                              1                     
  23.0 to 24.9              256   2.49 (1.46, 4.25)     0.001     2.22 (1.23, 4.01)    0.009     1.94 (1.06, 3.55)     0.032
  25.0 to 27.4              312   5.714 (3.48, 9.39)    \<0.001   5.66 (3.43, 9.34)    \<0.001   6.47 (3.53, 11.88)    \<0.001
  27.5 to 29.9              224   10.32 (5.64, 18.89)   \<0.001   10.95 (3.43, 9.34)   \<0.001   11.47 (5.11, 25.75)   \<0.001

BMI, body mass index; CI, confidence interval; OR, odds ratio.

Model 1: Adjusted for non-modifiable confounders: age, gender, ethnicity.

Model 2: Adjusted for all factors in Model 1 and modifiable confounders: education, physical activity, smoking, alcohol consumption, fruit and vegetable consumption, and sleep duration.
